Table 2.
Biomarkers | Primary tumors; n = 45 | Lymph node metastases; n = 30 | ||||||
---|---|---|---|---|---|---|---|---|
0 | 1+ | 2+ | 3+ | 0 | 1+ | 2+ | 3+ | |
HIF-1α | 10 | 24 | 11 | - | 5 | 13 | 12 | - |
GLUT-1 | 24 | 16 | 5 | - | 15 | 11 | 4 | - |
Ob | 9 | 15 | 18 | 3 | 4 | 9 | 14 | 3 |
ObR | 29 | 11 | 5 | 0 | 12 | 6 | 8 | 4 |
ERα | 17 | 10 | 11 | 7 | 10 | 6 | 6 | 8 |
ERβ | 9 | 9 | 23 | 4 | 5 | 5 | 13 | 7 |
Ki-67 | 17 | 20 | 8 | - | 11 | 13 | 6 | - |
n - number of studied cases.